437
Participants
Start Date
March 25, 2025
Primary Completion Date
October 15, 2027
Study Completion Date
October 15, 2027
BMS-986488
Specified dose on specified days
Adagrasib
Specified dose on specified days
Cetuximab
Specified dose on specified days
Nivolumab
Specified dose on specified days
NOT_YET_RECRUITING
Local Institution - 0031, Brisbane
RECRUITING
Lehigh Valley Health Network, Allentown
RECRUITING
The West Clinic, PLLC dba West Cancer Center, Germantown
NOT_YET_RECRUITING
Local Institution - 0025, Dallas
RECRUITING
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RECRUITING
BC Cancer Vancouver, Vancouver
NOT_YET_RECRUITING
Local Institution - 0015, Montreal
RECRUITING
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus, Québec
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY